The Trump administration negotiated MFN pricing deals with Novo Nordisk and Eli Lilly in November 2025, reducing Medicare/Medicaid prices for GLP-1 drugs to approximately $245/month ( [17] )
This is particularly true when considering regenerative therapies such as BPC-157, as different injuries may respond differently depending on their severity, duration, and underlying cause
When it comes to supporting both healing and gut health, combining BPC157 and KPV offers more than just individual benefits
Graham, PhD, MD, professor of radiology with the University of Iowa Health Care, who was not involved in the research, said, While weve not encountered such issues at University of Iowa Health Care, we are anticipating that we will eventually encounter abnormal FDG PET scans as the use of GLP-1 drugs becomes more common. Graham also described how increased FDG uptake might obscure abnormal findings and reduce the accuracy of FDG PET imaging, particularly in cases of cancer
GLP-1 medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.
[6] Muttenthaler M, et al